Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines

Salim S. Virani*, Julia M. Akeroyd, Sidney C. Smith, Mouaz Al-Mallah, Thomas M. Maddox, Pamela B. Morris, Laura A. Petersen, Christie M. Ballantyne, Scott M. Grundy, Neil J. Stone

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines'. Together they form a unique fingerprint.